Tag: Diabetes
Independent Voter Support for Ending Bush Limits on Stem Cell Lines is Strong
WASHINGTON, April 26 /PRNewswire/ -- Two out of three voters in 18 key states support overriding the Bush administration's limits on federal government funding...
Stem-cell funds slow in coming
Potential returns may be years away, and society’s moral concerns make investors nervous
SEATTLE — Whoever learns to control embryonic stem cells that can morph...
Linux on Power from IBM for Critical Stem Cell Research
Department of Molecular Biology Displaces Dell, Turns to IBM for Crucial Technology
NEW YORK, N.Y., April 1, 2004 - Today at a press conference in...
Stem-cell research is exciting, but not to investors
SEATTLE - (KRT) - Whoever learns to control embryonic stem cells that can morph into healthy human cells could be standing on a gold...
California Congressman Upsets Pro-Lifers With Embryonic Research Support
Washington, DC (LifeNews.com) -- A California Congressman who identifies himself as pro-life is drawing fire for his support of scientific research that results in...
The roots of the Stem Cell Controversy
The argument surrounding the research is multi-faceted. Here's a look at the science, politics and campus reaction behind the debate.
Although the ethical debate concerning...
Stem-cell research still an embryonic business
Whoever learns to control embryonic stem cells that can morph into healthy human cells could be standing on a gold mine: Four million Americans...
With some help from her friends
Whoever learns to control embryonic stem cells that can morph into healthy human cells could be standing on a gold mine: Four million Americans...
Human clones verified
For the first time, scientists have achievedhuman "therapeutic cloning," creating human embryos through cloning and extracting stem cells that were thenmorphed into other kinds...
Scientists Clone First Human Embryo
Genetically Identical Cells May One Day Cure Disease
Researchers in South Korea say they are the first to successfully clone a human embryo and use...
